Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018

Details for Mechanism ID: 17293
Country/Region: Tanzania
Year: 2015
Main Partner: Management and Development for Health
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $40,482,318 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $7,976,276
Care: TB/HIV (HVTB) $961,074
Care: Pediatric Care and Support (PDCS) $2,413,025
Laboratory Infrastructure (HLAB) $160,000
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $1,881,880
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $4,352,769
Treatment: Adult Treatment (HTXS) $20,324,269
Treatment: Pediatric Treatment (PDTX) $2,413,025
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 158,927
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 36,600
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 487,005
LAB_ACC Number of PEPFAR-supported testing facilities (laboratories) that are recognized by national, regional, or international standards for accreditation or have achieved a minimal acceptable level towards attainment of such accreditation 2016 11
LAB_CAP By clinical laboratories 2016 87
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2016 87
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 14,867
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 13,870
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 6,516
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 7,354
PMTCT_ARV Sum of New and Current disaggregates 2016 13,870
PMTCT_CTX Number of infants born to HIV-infected women who were started on cotrimoxizole (CTX) prophylaxis within 2 months of birth within the reporting period 2016 12,093
PMTCT_EID By infants who received a virologic test within 2 months of birth 2016 8,200
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2016 3,516
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 11,716
PMTCT_EID Sum of Infant Age disaggregates 2016 11,716
PMTCT_STAT By: Known positives at entry 2016 4,457
PMTCT_STAT By: Number of new positives identified 2016 10,400
PMTCT_STAT Number of new ANC and L&D clients 2016 254,763
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 242,588
PMTCT_STAT Sum of Positives Status disaggregates 2016 14,857
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 158,927
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 150,973
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 147,905
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 35,198
Cross Cutting Budget Categories and Known Amounts Total: $15,161,783
Food and Nutrition: Policy, Tools, and Service Delivery $165,040
Human Resources for Health $12,493,740
Gender: Gender Based Violence (GBV) $1,160,900
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Motor Vehicles: Purchased $221,924
Gender: Gender Equality $100,000
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Renovation $745,179
Key Populations: Sex Workers $200,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Key Populations: MSM and TG $75,000
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information